A Tumblr Takeover? ...
Health Care: Drugs
Theravance Inc. (THRX: NASDAQ)
$39.58 0.04 | 0.11%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -18.54M | -115.34M | -83.86M | -85.30M |
| Operating Gains/Losses | 187.00K | 0.00 | 33.00K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -841.00K | -29.00K | -448.00K | 2.76M |
| (Increase) Decrease in Inventories | -4.82M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -1.48M | 3.31M | -236.00K | -2.70M |
| (Decrease) Increase In Other Current Liabilities | -1.83M | 5.12M | 3.32M | -2.62M |
| (Increase) Decrease In Other Working Capital | -131.30M | -16.20M | -20.48M | 4.27M |
| Other Non-Cash Items | 23.78M | 24.93M | 19.02M | 19.99M |
| Net Cash From Continuing Operations | -127.95M | -88.34M | -75.14M | -58.06M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -127.95M | -88.34M | -75.14M | -58.06M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 12.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 274.63M | 248.80M | 143.88M | 123.06M |
| Purchases of Property, Plant & Equipment | -2.59M | -3.63M | -861.00K | -744.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -330.48M | -301.56M | -183.90M | -123.46M |
| Other Cash from Investing Activities | 60.00K | 715.00K | 557.00K | 2.88M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -58.28M | -55.82M | -40.31M | 1.74M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | 25.81M | 231.43M | 11.72M |
| Repayment of Long-Term Debt | -69.00K | -206.00K | -184.00K | -131.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 236.38M | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 236.31M | 25.60M | 231.24M | 11.59M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 50.07M | -118.56M | 115.79M | -44.74M |
Portfolios with THRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ProSeth Klarman - Baupost Group
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Usernew
Latest THRX Headlines from TheStreet
- Stocks Finish Flat as Earnings Wind Down 05.13.13 | 11:05 am
- Stock Futures Lower Ahead of Retail Sales 05.13.13 | 06:05 am
- 4 Stocks Spiking on Big Volume 05.10.13 | 03:05 pm
- Buffett's Long-Term, High-Dividend Plays 05.04.13 | 03:05 am
- Theravance Inc. (THRX): Today's Featured Health Care Laggard 04.19.13 | 05:04 pm
- 3 Stocks Pushing The Drugs Industry Higher 04.15.13 | 01:04 pm
- 5 Stocks Poised to Pop on Bullish Earnings 02.11.13 | 12:02 pm
- Insiders Trading THRX KSS TUES ELGX 11.06.12 | 10:11 am
- Theravance And Merck Sign Cardiovascular Disease Collaboration 10.16.12 | 08:10 am
- Theravance And Alfa Wassermann Enter Into Agreement To Develop And Commercialize Velusetrag For Gastroparesis 10.02.12 | 04:10 pm
Press Releases for THRX
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
Partner Headlines for THRX
- Theravance, Glaxo, Elan Star In Biotech Soap Opera - Investor's Business Daily 05.13.13 | 05:05 pm
- Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD - Benzinga 05.10.13 | 12:05 pm
- Theravance Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 04.25.13 | 08:04 am
- Morning Market Movers - Benzinga 04.15.13 | 09:04 am
- Pipeline Progress at Theravance - Analyst Blog - Zacks 12.05.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Loss at THRX Narrower Than Expected - Analyst Blog - Zacks 10.31.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
